⌘K

Login Start Free

Home/Filings/4/0001104659-22-073497

4//SEC Filing

Schafer Klaus 4

Accession 0001104659-22-073497

CIK 0001326190other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:10 PM ET

Size

23.5 KB

Accession

0001104659-22-073497

Insider Transaction Report

Form 4

Period: 2022-06-20

Altimmune, Inc.ALT

Director

Transactions

Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+159$382→ 9,119 total
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−60→ 0 total
Exercise: $2.40Exp: 2022-12-30→ Common Stock, par value $0.0001 (60 underlying)
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−60→ 0 total
Exercise: $2.40Exp: 2022-07-04→ Common Stock, par value $0.0001 (60 underlying)
Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+60$144→ 8,960 total
Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+60$144→ 9,179 total
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−159→ 0 total
Exercise: $2.40Exp: 2022-07-04→ Common Stock, par value $0.0001 (159 underlying)

Footnotes (3)

[F1]This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018.
[F2]This option was previously reported as covering 4,775 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018.
[F3]This option is fully vested and exercisable as of the date hereof.

Documents

2 files

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1

filerCIK 0001705904

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 4:10 PM ET
Size: 23.5 KB

View on SEC.gov